Factor D

Hideharu Sekine1, Takeshi Machida1, Teizo Fujita2

  • 1Department of Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Immunological Reviews
|November 1, 2022
PubMed

Insights

Complement factor D (FD) activation, crucial for the alternative pathway (AP), requires MASP-3. This discovery clarifies how FD is physiologically activated, impacting complement system research.

Area of Science:

  • Immunology
  • Biochemistry
  • Complement System Biology

Background:

  • Complement factor D (FD) is a serine protease essential for alternative pathway (AP) activation.
  • FD, primarily from adipose tissue, circulates in an activated form, unlike most liver-synthesized complement proteases.
  • The mechanism of FD activation remained largely unknown until recent discoveries.

Purpose of the Study:

  • To elucidate the mechanism of complement factor D (FD) activation.
  • To investigate the role of MASP-1 and MASP-3 in FD activation.
  • To clarify the physiological activation of the AP via FD.

Main Methods:

  • Utilized MASP-1/3-deficient mice and MASP-1 or MASP-3 monospecific knockout mice.
  • Analyzed sera from these knockout mice for lectin pathway (LP) and AP activity.
  • Examined sera from 3MC syndrome patients with MASP1 gene mutations.

Main Results:

  • MASP-1/3-deficient mice sera showed minimal LP and AP activity with pro-FD.
  • MASP-1-deficient mice sera lacked LP activity.
  • MASP-3-deficient mice sera lacked AP activity with pro-FD, indicating MASP-3's crucial role.

Conclusions:

  • MASP-1 and/or MASP-3 are involved in the activation of FD.
  • MASP-3 plays a pivotal role in the physiological activation of the AP through FD activation.
  • This research clarifies a key step in complement system regulation.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.8K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
849